Carroll J Martin
- SEC CIK
- 0001279901
No open-market purchases or sales filed in the past year.
Current role at each company
- ESPR Esperion Therapeutics, Inc.Directoras of Jul 13, 2026
- CTLT Catalent, Inc.Directoras of Dec 18, 2024
- MNKTQ Keenova Therapeutics plcDirectoras of Jun 21, 2022
- TXMD TherapeuticsMD, Inc.Directoras of Aug 12, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Carroll J Martin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ESPR Esperion Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing) | May 10-11 | 1 day | Carroll J MartinDirector | PPurchase | +31.5K | $1.55 | +$48.8K | +630.0%36.5K after | 2 lots |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Carroll J MartinDirector | PPurchase | +5.00K | $5.64 | +$28.2K | New position5.00K after |